DTB Select: Patiromer plus spironolactone in resistant hypertension and CKD

Summary and context are provided for an RCT (n=295) in people with resistant hypertension and chronic kidney disease which found that more people in the patiromer arm could continue taking spironolactone vs the placebo arm (owing to less hyperkalaemia).

Source:

Drug and Therapeutics Bulletin